Navigation Links
Fluoropharma Medical To Present At Taglich Brothers 10th Annual Small Cap Equity Conference
Date:4/18/2013

New York, NY (PRWEB) April 18, 2013

Taglich Brothers, Inc. is pleased to announce that Thijs Spoor, President & CEO of FluoroPharma Medical, Inc. (OTCB: FPMI) will be presenting at their 10th Annual Small Cap Equity Conference May 7, 2013. The Conference will take place at the New York Athletic Club, New York City. To request additional information or to register, contact Taglich Brothers at 212-779-2971 or visit http://www.TaglichBrothers.com.

About Taglich Brothers:
Taglich Brothers, Inc. is a full-service broker dealer focused exclusively on microcap companies. The Company defines the microcap segment of the equity market as companies with less than $250 million in market capitalization. Taglich Brothers currently offers institutional and retail brokerage services, investment banking and comprehensive research coverage to the investment community.

About FluoroPharma Medical, Inc.:
FluoroPharma is a biopharmaceutical company engaged in the discovery and development of proprietary PET imaging products to evaluate cardiac disease at the cellular and molecular levels. The Company has licensed technology from the Massachusetts General Hospital in Boston.

The Company's goal is to enable personalized medicine through precision diagnostics that will help the medical community diagnose disease more accurately at the earliest stages, leading to more effective treatment, management and better patient outcomes.

FluoroPharma's initial focus is the development of breakthrough positron emission tomography (PET) imaging agents and is advancing two products in clinical trials for assessment of acute and chronic forms of coronary disease. These first in class agents have been designed to rapidly target myocardial cells. Other products in development include agents for detection of inflamed atherosclerotic plaque in peripheral arteries, agents with the potential to image Alzheimer's disease and agents that could potentially be used for imaging specific cancers.

In addition to the United States, Europe and China, patents related to FluoroPharma's portfolio of imaging compounds have been issued in Japan, Canada, Australia, Finland, Portugal, Ireland and Mexico. For more information on the Company, please visit: http://www.fluoropharma.com

Contact:
Taglich Brothers                    
Karen Payne, Symposia Events
212-779-2971

Read the full story at http://www.prweb.com/releases/taglichbrothers/equityconference/prweb10645606.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New QuickMedical Facility Offers More Products and Enhanced Service
2. JustHomeMedical.com Launches New Bath Lifts Category
3. Magnet hospitals achieve lower mortality, reports Medical Care
4. Physician entrepreneurs are key contributors to new medical devices
5. Dr. Buckingham of Buckingham Center for Facial Plastic Surgery Re-Elected as Texas Medical Association Delegate
6. Automated Security Alert's New Medical Alarm Systems Provide A Variety Of Help
7. Christopher Jayne, M.D., Receives InTone Specialist Certification To Treat Female Urinary Incontinence From InControl Medical, LLC
8. To Stop Medical Mistakes, TOPGUN Fighter Pilot Shares Hidden Technology Secrets With Operating Room Staff At National Medical Convention
9. Travel Nursing Jobs Leader, Aureus Medical, Makes Recommendations for a Travel Nurse to Grow Professionally
10. Nuviva Medical Weight Loss Opens new Clinic in Lake Mary - Orlando
11. Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the American Occupational Therapy Association’s 93rd Annual Conference & Expo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... , ... The president released a FY 2017 budget request on Tuesday that ... the cost burden to military beneficiaries. , MOAA’s president, retired Air Force Lt. ... including limited quantifiable benefit fixes mixed with numerous beneficiary fee hikes. , “We were ...
(Date:2/11/2016)... ... 2016 , ... The Chartis Group, a national advisory services ... the “2015/2016 Best in KLAS: Software and Services” report in two categories: IT ... insights firm on a global mission to improve healthcare delivery by amplifying the ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... to reverse diabetes has been gearing up for their simultaneous grand openings in ... It’s about right now that you’re probably wondering, is reversing diabetes possible? According ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... advocates will discuss how to improve care by making data on heart procedures ... disease. The Summit on Transparency and Public Reporting of Pediatric and Congenital Heart ...
(Date:2/11/2016)... ... February 11, 2016 , ... Thermi™, a world leader ... to announce the promotions of Allison Kelly to executive vice president of the ... vice president of North American capital sales, and Wendy Oseas to vice president ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... , Feb. 11, 2016 Potrero Medical, Inc., ... pleased to announce the appointment of George M. Rapier, ... San Antonio, TX , WellMed is one of ... 200,000 patients and HMO members in Texas ... in 1990 out of his own internal medicine practice, he ...
(Date:2/11/2016)... , Feb. 11, 2016  NOIT™ Research LLC, a ... "Gift of Change" campaign to assist needy families in ... such unit sold between February 10, 2016 and March ... a needy family. The NOIT is an auditory stimulus ... individuals develop language skills. Beth Shier ...
(Date:2/11/2016)... , Feb. 11, 2016  MiMedx Group, Inc. ... utilizing human amniotic membrane and other birth tissues, human ... to develop and market advanced products and therapies, announced ... Markets, 2016 Global Healthcare Conference in New ... and CEO, Michael J. Senken , Chief Financial ...
Breaking Medicine Technology: